Toyoda H - Search Results

1

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.

Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: toyoda h. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649

2

Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Toyoda H, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):111-7. doi: 10.1016/s1542-3565(05)00855-4. Clin Gastroenterol Hepatol. 2006. PMID: 16431313

3

Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Toyoda H, et al. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1170-6. doi: 10.1016/j.cgh.2006.06.007. Epub 2006 Aug 2. Clin Gastroenterol Hepatol. 2006. PMID: 16890027

4

Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.

Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T. Toyoda H, et al. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1528-36. doi: 10.1016/j.cgh.2006.09.021. Clin Gastroenterol Hepatol. 2006. PMID: 17162244

5

Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.

Toyoda H, Kumada T, Kaneoka Y, Murakami Y. Toyoda H, et al. J Hepatol. 2008 Jan;48(1):43-50. doi: 10.1016/j.jhep.2007.08.016. Epub 2007 Oct 24. J Hepatol. 2008. PMID: 18023912

6

High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Arakawa T, Fujimori M, Niinomi T, Ando N, Yasuda S, Sakai K, Kimura J. Toyoda H, et al. J Gastroenterol. 2011 Apr;46(4):501-9. doi: 10.1007/s00535-010-0328-z. Epub 2010 Oct 7. J Gastroenterol. 2011. PMID: 20927636

7

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology. Kudo M, et al. Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027

8

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis.

Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J. Kumada T, et al. Among authors: toyoda h. J Hepatol. 2013 Mar;58(3):427-33. doi: 10.1016/j.jhep.2012.10.025. Epub 2012 Oct 30. J Hepatol. 2013. PMID: 23123221

9

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

Honda T, Ishigami M, Masuda H, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Katano Y, Goto H. Honda T, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2015 Feb;30(2):321-8. doi: 10.1111/jgh.12703. J Gastroenterol Hepatol. 2015. PMID: 25091027

10

Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray.

Murakami Y, Tanahashi T, Okada R, Toyoda H, Kumada T, Enomoto M, Tamori A, Kawada N, Taguchi YH, Azuma T. Murakami Y, et al. Among authors: toyoda h. PLoS One. 2014 Sep 12;9(9):e106314. doi: 10.1371/journal.pone.0106314. eCollection 2014. PLoS One. 2014. PMID: 25215888 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,442 results

Search Page